ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,046.58
      0.72%
      US Tech 100
      16,846.40
      0.56%
      Dow Jones
      38,400.34
      0.42%
      Brent Oil
      86.14
      -0.31%
      Bitcoin
      66,545.47
      -0.47%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Seres Therapeutics Inc (MCRB)

      7. Seres Therapeutics Inc (MCRB) News

      MCRB Seres Therapeutics Inc

      0.63
      0.0054 (0.86%)
      Last Updated: 09:39:34
      Delayed by 15 minutes
      Company Name Stock Ticker Symbol Market Type
      Seres Therapeutics Inc MCRB NASDAQ Common Stock
        Price Change Change Percent Stock Price Last Traded
      Upgrade Icon
      0.0054 0.86% 0.63 09:39:34
      Open Price Low Price High Price Close Price Prev Close
      0.639 0.6288 0.6397 0.6246
      more quote information »

      Recent News

      Date Time Source Heading
      4/22/20248:49IHNWFeaturedCannabix Technologies to Present Marijuana Breathalyzer Technology at International Association for Chemical Testing (IACT) Conference in California
      4/09/202407:00BWSeres Therapeutics Announces Completion of Patient..
      3/28/202407:00BWSeres Therapeutics Reports Inducement Grants Under Nasdaq..
      3/19/202407:00BWSeres Therapeutics Reports Inducement Grants Under Nasdaq..
      3/05/202410:18EDGAR2Form DEF 14A - Other definitive proxy statements
      3/05/202410:13EDGAR2Form S-8 - Securities to be offered to employees in employee..
      3/05/202407:05EDGAR2Form 8-K - Current report
      3/05/202407:00BWSeres Therapeutics Reports Fourth Quarter and Full Year 2023..
      3/05/202406:05IHMARKETNEWSU.S. Futures Dip, Crude Oil Fluctuates
      2/28/202407:00BWSeres Therapeutics to Host Fourth Quarter 2023 Financial..
      2/27/202407:00BWSeres Therapeutics to Participate in Cowen 44th Annual..
      2/26/202407:06EDGAR2Form 8-K - Current report
      2/26/202407:00BWSeres Therapeutics Announces the Appointment of Marella..
      2/23/202416:05EDGAR2Form PRE 14A - Other preliminary proxy statements
      2/16/202421:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      2/16/202421:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      2/16/202421:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      2/16/202421:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      2/16/202421:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      1/30/202416:01EDGAR2Form 8-K - Current report
      1/17/202407:00BWSeres Therapeutics Reports Inducement Grants Under Nasdaq..
      1/10/202407:00EDGAR2Form 8-K - Current report
      1/09/202408:10DJNSeres Therapeutics Shares Rise 15% After Getting FDA..
      1/09/202407:05EDGAR2Form 8-K - Current report
      1/09/202407:00BWSeres Therapeutics Announces VOWST™ Commercial Launch Update..
      1/04/202416:00BWSeres Therapeutics to Participate in the 42nd Annual J.P...
      1/02/202416:05EDGAR2Form 8-K - Current report
      12/07/202319:46BWSeres Therapeutics Announces Presentation of Preliminary..
      11/28/202309:18BWSeres Therapeutics to Participate in the Piper Sandler 35th..
      11/27/202319:01PRNUSFlagship Pioneering Marks Official Opening of UK Hub with..
      11/21/202306:00PRNUSFlagship Pioneering Unveils Quotient Therapeutics to Create..
      11/02/202310:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
      11/02/202307:05EDGAR2Form 8-K - Current report
      11/02/202307:00BWSeres Therapeutics Reports Third Quarter 2023 Financial..
      11/01/202310:30PRNUSFlagship Pioneering Launches Pioneering Intelligence
      10/31/202321:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      10/31/202321:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      10/31/202321:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      10/31/202321:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      10/31/202321:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      10/31/202321:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      10/30/202317:30BWSeres Therapeutics to Announce Third Quarter 2023 Results on..
      10/12/202307:00BW Seres Therapeutics to Highlight VOWST™ Data at IDWeek
      10/06/202307:00BWSeres Therapeutics Reports Inducement Grants Under Nasdaq..
      10/04/202307:00EDGAR2Form 8-K - Current report
      9/11/202306:30PRNUSFlagship Pioneering Announces Appointment of Amanda Kay as..
      9/08/202307:00BWSeres Therapeutics Reports Inducement Grants Under Nasdaq..
      9/07/202310:00BWSeres Therapeutics to Participate in the Morgan Stanley 21st..
      8/29/202309:00PRNUSInvaio achieves first registration for citrus greening..
      8/16/202300:15EDGAR2Form EFFECT - Notice of Effectiveness
      8/08/202316:07EDGAR2Form S-3 - Registration statement under Securities Act of..

      Your Recent History

      NASDAQ
      MCRB
      Seres Therapeutics
      Delayed Upgrade Clock